AMS Study: Inflammatory and Biomechanical Contributors to Arthritis Development Following Arthroscopic Meniscectomy
NCT ID: NCT00752271
Last Updated: 2009-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
32 participants
OBSERVATIONAL
2008-05-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
24 adults with meniscal damage for which arthroscopy is clinically indicated
No interventions assigned to this group
2
8 adults who have already undergone meniscal resection to serve as positive controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Potential candidate for knee arthroscopy for medial
* Meniscal tear confirmed on MRI
* Prior meniscal resection at least 1 year prior with a persistent knee effusion
* Body mass index between 25-35 kg/m2
Exclusion Criteria
* Knee surgery within 1 year before the initial study evaluation
* Pace-maker or defibrillator, 2nd or 3rd degree heart block, or other abnormal rhythms
* Current diagnosis of diabetes mellitus, a fasting glucose\>100mg/dl or \>140 mg/dl 2 hour after a glucose challenge
* Current diagnosis of an inflammatory condition (e.g. rheumatoid arthritis, gout, etc)
* Untreated thyroid disease
* Morbid obesity (body mass index \>35)
* Neuropathy or nerve damage
* Stroke or transient-ischemic attacks (mini-stroke)
* Recent diagnosis of congestive heart failure or heart attack
* Use of prednisone or chemotherapy, steroid or other joint or ant-inflammatory agents in the past 3 months
* Current use of medications that influence heart rate
* Cognitive impairment that limits your ability to provide informed consent
* Pregnancy
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
National Institute on Aging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shari M. Ling, MD
Role: PRINCIPAL_INVESTIGATOR
National Institute on Aging (NIA)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIA Clinical Research Unit
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu Rev Biochem. 2005;74:385-410. doi: 10.1146/annurev.biochem.72.121801.161747.
Roos EM. Joint injury causes knee osteoarthritis in young adults. Curr Opin Rheumatol. 2005 Mar;17(2):195-200. doi: 10.1097/01.bor.0000151406.64393.00.
Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, Tracey KJ, Al-Abed Y, Metz CN. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med. 2005 Apr 4;201(7):1113-23. doi: 10.1084/jem.20040463.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AG0105
Identifier Type: -
Identifier Source: org_study_id